Marta Covela Rúa

Efficacy and safety of FOLFIRI/aflibercept in second‐line treatment of metastatic colorectal cancer in a real‐world population: Prognostic and predictive markers

Ana Fernández Montés, Nieves Martínez Lago, Marta Covela Rúa et al. · Cancer Medicine · 2019 · 37 citations · Full text

Immunological Biomarkers of Fatal COVID-19: A Study of 868 Patients

Esperanza Martín‐Sánchez, Juan‐José Garcés, Catarina Maia et al. · Frontiers in Immunology · 2021 · 32 citations · Full text

Vaccination, Coronavirus Disease 2019, Long Covid +15

Efficacy and safety of trifluridine/tipiracil in third-line and beyond for the treatment of patients with metastatic colorectal cancer in routine clinical practice: patterns of use and prognostic nomogram

Ana Fernández Montés, Francisca Rivera, Nieves Martínez Lago et al. · Clinical & Translational Oncology · 2019 · 15 citations

Oncology, Cancer Management, Colorectal Cancer +7

FOLFIRI plus panitumumab as second-line treatment in mutated RAS metastatic colorectal cancer patients who converted to wild type RAS after receiving first-line FOLFOX/CAPOX plus bevacizumab-based treatment: Phase II CONVERTIX trial

Ana Fernández Montés, Nieves Martínez Lago, J. de la Cámara Gómez et al. · Annals of Oncology · 2019 · 15 citations · Full text

Second-line Treatment, Type Ras, Oncology +8

Prediction of survival in patients with advanced, refractory colorectal cancer in treatment with trifluridine/tipiracil: real-world vs clinical trial data

Ana Fernández Montés, Alberto Carmona‐Bayonas, Paula Jiménez‐Fonseca et al. · Scientific Reports · 2021 · 12 citations · Full text